Sodium cromoglicate - Nxera Pharma
Alternative Names: cromolyn sodium - Nxera PharmaLatest Information Update: 02 Apr 2024
At a glance
- Originator Sosei Heptares
- Developer Nxera Pharma
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Preclinical Pain